CIK 0001704292 · Large accelerated filer
Zai Lab Ltd
Sign in to watch- Ticker
- ZLAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 862161632588
- Business address
- 899 HALEI ROAD, BUILDING B, PUDONG, SHANGHAI, China
- Former names
- Zai Lab Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,020
- in 1 filing, $7K under 10b5-1 plans
Net −$7,020. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-11 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $0.60 | $30K | 586,962 |
| 2025-08-11 | Du Ying Chairperson & CEO | Sale 10b5-1 | −50,000 | $34.64 | $1.7M | 536,962 |
| 2025-08-11 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 96,387 | ||
| 2025-08-08 | Amado Rafael See Remarks | Sale 10b5-1 | −3,000 | $35.00 | $105K | 42,178 |
| 2025-08-08 | Chen Yajing Chief Financial Officer | Sale 10b5-1 | −4,096 | $34.01 | $139K | 16,908 |
| 2025-08-08 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $0.60 | $30K | 586,962 |
| 2025-08-08 | Du Ying Chairperson & CEO | Sale 10b5-1 | −50,000 | $34.74 | $1.7M | 536,962 |
| 2025-08-08 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 146,387 | ||
| 2025-07-02 | Du Ying Chairperson & CEO | Grant or award · Restricted Share Units | +44,194 | 44,194 | ||
| 2025-07-02 | Du Ying Chairperson & CEO | Sale | −7,072 | $35.23 | $249K | 536,962 |
| 2025-07-01 | Du Ying Chairperson & CEO | Option exercise | +18,000 | 544,034 | ||
| 2025-07-01 | Du Ying Chairperson & CEO | Option exercise · Restricted Share Units | −18,000 | 54,000 | ||
| 2025-06-30 | Du Ying Chairperson & CEO | Sale | −6,918 | $35.52 | $246K | 526,034 |
| 2025-06-27 | Du Ying Chairperson & CEO | Option exercise | +17,970 | 532,952 | ||
| 2025-06-27 | Du Ying Chairperson & CEO | Option exercise · Restricted Share Units | −17,970 | 35,940 | ||
| 2025-06-26 | Edmondson Frazor Titus III Chief Legal Officer | Sale | −5,877 | $36.13 | $212K | 39,098 |
| 2025-06-26 | Du Ying Chairperson & CEO | Sale | −23,669 | $36.13 | $855K | 514,982 |
| 2025-06-26 | Chen Yajing Chief Financial Officer | Sale | −2,675 | $36.13 | $97K | 21,004 |
| 2025-06-25 | Edmondson Frazor Titus III Chief Legal Officer | Option exercise | +14,600 | 44,975 | ||
| 2025-06-25 | Edmondson Frazor Titus III Chief Legal Officer | Option exercise · Restricted Share Units | −14,600 | 14,600 |
Page 10 of 15 · 295 trades